What Is PMOS?<\/strong><\/span><\/h2>\nPMOS stands for Polyendocrine Metabolic Ovarian Syndrome<\/strong>.<\/p>\nPMOS is the same condition that was previously known as PCOS, or polycystic ovary syndrome. This change does not mean that a new disease has been discovered. Instead, the new name is intended to better represent the true and complex nature of the condition.<\/p>\n
This syndrome may simultaneously affect several areas, including:<\/strong><\/p>\n\n- Regulation of sex hormones and androgens<\/li>\n
- Insulin function and blood glucose control<\/li>\n
- Fat metabolism and body weight<\/li>\n
- Ovulation and ovarian function<\/li>\n
- The menstrual cycle<\/li>\n
- Skin and hair health<\/li>\n
- Mental health and quality of life<\/li>\n
- Fertility and health during pregnancy<\/li>\n<\/ul>\n
International guidelines describe PMOS as the most common endocrine disorder during the reproductive years, with effects that may continue from adolescence through the years following menopause. (Monash University)<\/p>\n
Why Was PCOS Renamed PMOS?<\/strong><\/span><\/h2>\n![\"\u0686\u0631\u0627](\"https:\/\/drshojaeiazar.com\/wp-content\/uploads\/2026\/07\/pmos-6-1024x768.png\")
<\/p>\n
For several decades, the name PCOS was associated with scientific and communication-related problems. The term \u201cpolycystic\u201d led patients and even some healthcare providers to believe that the presence of multiple ovarian cysts was the main or essential feature of the condition.<\/p>\n
The renaming process took approximately 14 years and involved specialists, researchers, people with lived experience of the condition, and 56 professional and patient advocacy organizations. More than 22,000 survey responses were collected. Criteria such as scientific accuracy, reduction of social stigma, suitability for use across different cultures, and improvement of medical care contributed to the selection of the new name. (Monash University)<\/p>\n
The Term \u201cPolycystic\u201d Was Misleading<\/strong><\/span><\/h3>\nOne of the most important reasons for the name change is that affected individuals do not necessarily have ovarian cysts. What is observed in some ultrasound examinations is a collection of small follicles whose development or maturation has been interrupted.<\/p>\n
On the other hand, a person may have polycystic ovarian morphology on ultrasound without meeting the other criteria required for the diagnosis of the syndrome. Therefore:<\/p>\n
\n- The absence of polycystic ovarian morphology does not rule out PMOS.<\/li>\n
- Having ovaries with polycystic morphology is not sufficient on its own for diagnosis.<\/li>\n
- The presence of true cysts is not a diagnostic requirement for PMOS.<\/li>\n<\/ul>\n
The World Health Organization also emphasizes that some affected individuals do not have polycystic ovarian morphology and that the presence of cysts is not necessary for diagnosis. (World Health Organization)<\/p>\n
The Condition Is Not Limited to the Ovaries<\/strong><\/span><\/h3>\nThe name PCOS primarily directed attention toward the ovaries and fertility. However, the condition may also be associated with insulin resistance, impaired glucose tolerance, type 2 diabetes, abnormal blood lipid levels, sleep apnea, psychological problems, and an increased risk of certain pregnancy complications. (World Health Organization)<\/p>\n
The name PMOS reminds both physicians and patients that evaluation of the condition should not be limited to an ovarian ultrasound or the treatment of menstrual irregularities.<\/p>\n
What Exactly Does PMOS Mean?<\/strong><\/span><\/h2>\nEach component of the name PMOS represents one of the main dimensions of the condition.<\/p>\n
Polyendocrine: Involvement of Multiple Hormonal Pathways<\/strong><\/span><\/h3>\nPolyendocrine refers to the involvement of several hormonal pathways or systems. In PMOS, there is a complex interaction between ovarian hormones, androgens, insulin, and neuroendocrine signals.<\/p>\n
Elevated androgen levels or increased sensitivity of the body to androgens may be associated with symptoms such as excessive hair growth, acne, and thinning of scalp hair.<\/p>\n
Metabolic: The Importance of Metabolic Health<\/strong><\/span><\/h3>\nThe term \u201cmetabolic\u201d emphasizes the role of metabolism, particularly abnormalities in blood glucose regulation. Regardless of age or body mass index, affected individuals may have a greater risk of impaired glucose tolerance and type 2 diabetes.<\/p>\n
International guidelines recommend assessing blood glucose status at the time of diagnosis and continuing subsequent evaluations based on individual risk factors. A 75-gram oral glucose tolerance test is the most accurate recommended method for assessing glucose status in PMOS, although a physician may also use fasting blood glucose or HbA1c in different circumstances. (ASRM)<\/p>\n
Ovarian: The Continuing Importance of Ovarian Function<\/strong><\/span><\/h3>\nAlthough PMOS extends beyond an ovarian disorder, ovarian function remains one of its central components. Abnormal follicular development, irregular or absent ovulation, and changes in menstrual cycles may affect fertility.<\/p>\n
Therefore, the term \u201covarian\u201d has been retained in the new name, but the presence of \u201ccysts\u201d is no longer presented as the central feature of the condition.<\/p>\n
Is PMOS a New Disease?<\/strong><\/span><\/h2>\nNo. PMOS is the same condition as PCOS, but with a more accurate name.<\/p>\n
As a result of the name change:<\/p>\n
\n- No new disease has been created or discovered.<\/li>\n
- People who were previously diagnosed with PCOS now have PMOS.<\/li>\n
- The main symptoms of the condition have not suddenly changed.<\/li>\n
- Current diagnostic criteria have not been completely altered because of the new name.<\/li>\n
- Treatment principles continue to be determined according to each person\u2019s symptoms, metabolic status, and fertility goals.<\/li>\n<\/ul>\n
During the transition period, physicians and healthcare centers may use terms such as \u201cPCOS\/PMOS\u201d or \u201cPMOS, formerly known as PCOS.\u201d The international transition plan is expected to take three years, with broader implementation of the new name continuing alongside the update of the international guidelines in 2028. (Monash University)<\/p>\n
What Are the Symptoms of PMOS?<\/strong><\/span><\/h2>\nThe symptoms of PMOS are not the same in every individual, and their severity may also change throughout life. Some people primarily experience menstrual problems, while others seek medical attention because of acne, excessive hair growth, weight gain, or difficulty becoming pregnant.<\/p>\n
Irregular Menstrual Cycles<\/strong><\/span><\/h3>\nIrregular periods, long intervals between periods, or the absence of menstruation may result from irregular ovulation. Some individuals may also experience prolonged, heavy, or painful periods.<\/p>\n
Excessive Hair Growth<\/strong><\/span><\/h3>\nThe growth of thick, dark hair on the face, chin, neck, chest, abdomen, or other areas of the body may be associated with elevated androgen levels.<\/p>\n
Acne and Oily Skin<\/strong><\/span><\/h3>\nRecurrent or treatment-resistant acne, particularly around the jawline, chin, and lower face, may be a sign of increased androgen activity.<\/p>\n
Thinning of Scalp Hair<\/strong><\/span><\/h3>\nSome affected individuals may experience hair loss or thinning in a pattern similar to androgenetic alopecia.<\/p>\n
Weight Gain or Difficulty Managing Weight<\/strong><\/span><\/h3>\nPMOS may be associated with increased abdominal fat or difficulty managing body weight. However, the condition does not occur only in people who are overweight. Individuals with a normal body weight may also have PMOS.<\/p>\n
Ovulation and Pregnancy Difficulties<\/strong><\/span><\/h3>\nIrregular or absent ovulation can make it difficult to determine the appropriate timing for conception. PMOS is one of the common causes of infertility associated with ovulatory dysfunction, but a diagnosis does not mean that pregnancy is impossible. (World Health Organization)<\/p>\n
Sleep and Mental Health Problems<\/strong><\/span><\/h3>\nSleep apnea, anxiety, depression, body image concerns, and reduced quality of life are more common among some affected individuals. International guidelines recommend considering depression screening in affected adults and adolescents and anxiety screening in adults. (ASRM)<\/p>\n
How Is Insulin Resistance Related to PMOS?<\/strong><\/span><\/h2>\n![\"\u0639\u0644\u0627\u0626\u0645](\"https:\/\/drshojaeiazar.com\/wp-content\/uploads\/2026\/07\/pmos-5-1024x768.png\")
<\/p>\n
One of the most important messages conveyed by the new name is the greater emphasis placed on metabolic health.<\/p>\n
Insulin is a hormone that helps glucose move from the bloodstream into the body\u2019s cells. In insulin resistance, the cells do not respond properly to this hormone, so the body produces more insulin to compensate.<\/p>\n
Elevated insulin levels can stimulate the ovaries to produce more androgens. This process may worsen ovulation problems, menstrual irregularities, acne, and excessive hair growth.<\/p>\n
However, insulin resistance is not the only cause of PMOS, and not all patients have the same metabolic symptoms. PMOS is a heterogeneous syndrome, and genetic, environmental, hormonal, and metabolic factors may all contribute to its development.<\/p>\n
How Is PMOS Diagnosed?<\/strong><\/span><\/h2>\nThe new name PMOS does not replace clinical evaluation. Diagnosis must be made by a physician after reviewing the symptoms, menstrual history, physical examination findings, laboratory tests, and excluding other conditions with similar symptoms.<\/p>\n
In adults, diagnosis is generally based on the presence of at least two of the following three criteria:<\/p>\n
\n- Ovulatory dysfunction or irregular ovulation<\/li>\n
- Clinical or biochemical signs of elevated androgen levels<\/li>\n
- Polycystic ovarian morphology on ultrasound or, under certain conditions, assessment of anti-M\u00fcllerian hormone, or AMH<\/li>\n<\/ol>\n
The presence of the first two criteria may allow a diagnosis to be made without ultrasound or AMH testing. In addition, AMH should not be used on its own to diagnose PMOS and is not currently recommended for the diagnosis of adolescents. (ASRM)<\/p>\n
Diagnosing PMOS in Adolescents<\/strong><\/span><\/h3>\nDiagnosis in adolescents should be approached more cautiously because menstrual irregularities and acne may be part of the normal process of puberty during the first few years after menstruation begins.<\/p>\n
The use of ultrasound or AMH as diagnostic criteria is not recommended in adolescents. In cases where the complete diagnostic criteria are not met, the individual may be considered \u201cat risk of PMOS\u201d and reassessed in later years. (ASRM)<\/p>\n
Does PMOS Cause Infertility?<\/strong><\/span><\/h2>\nPMOS can affect fertility, but having the condition does not mean that infertility is inevitable. Many affected individuals become pregnant naturally or with appropriate treatment.<\/p>\n
The main ways in which PMOS may affect fertility include:<\/strong><\/p>\n\n- Irregular or absent ovulation<\/li>\n
- Difficulty determining the timing of ovulation<\/li>\n
- Hormonal abnormalities<\/li>\n
- Metabolic problems<\/li>\n
- An increased risk of certain pregnancy complications<\/li>\n<\/ul>\n
Before beginning infertility treatment, the physician evaluates not only ovulation but also age, ovarian reserve, the condition of the fallopian tubes, the partner\u2019s semen analysis, and other possible fertility factors.<\/p>\n
Does Everyone With PMOS Need IVF?<\/strong><\/span><\/h2>\nNo. IVF is only one of the available infertility treatments, and not everyone with PMOS requires it.<\/p>\n
For women with infertility caused by anovulation who have no other infertility factors, international guidelines identify letrozole as the first-line medication for ovulation induction. Depending on the individual\u2019s circumstances, other options such as clomiphene, metformin, gonadotropins, intrauterine insemination, or IVF may also be considered. The treatment method must be selected under the supervision of a specialist. (ASRM)<\/p>\n
Is the Treatment of PMOS Different From the Treatment of PCOS?<\/strong><\/span><\/h2>\nAt present, the name change itself has not created a new treatment. The main message of PMOS is that treatment should address all relevant aspects of the condition rather than focusing only on the ovaries or fertility.<\/p>\n
Lifestyle Modification<\/strong><\/span><\/h3>\nA balanced diet, physical activity, adequate sleep, reduced sedentary behavior, and stress management are among the foundations of PMOS care.<\/p>\n
International guidelines recommend healthy behaviors for all affected individuals, even when these changes do not result in weight loss. The goal is not only to reduce the number on the scale. Improving metabolic health, quality of life, body composition, and preventing weight gain are also important. (ASRM)<\/p>\n
Regulating Menstruation and Controlling Androgen-Related Symptoms<\/strong><\/span><\/h3>\nCombined oral contraceptive pills may be prescribed for some individuals to regulate menstrual cycles, reduce excessive hair growth, or control acne. The type of medication should be selected according to cardiovascular status, blood clot risk factors, the patient\u2019s preferences, and possible contraindications. (ASRM)<\/p>\n
Managing Metabolic Problems<\/strong><\/span><\/h3>\nMetformin may be considered for some adults, particularly those with greater metabolic risk, to improve glucose-related indicators, insulin resistance, or blood lipid levels. This medication is not necessary for every patient and should only be used when prescribed by a physician. (ASRM)<\/p>\n
Treating Fertility Problems<\/strong><\/span><\/h3>\nFertility treatment is selected according to the cause of infertility, age, ovulation status, and the individual\u2019s reproductive goals. Ovulation induction, timed intercourse, IUI, and IVF are among the possible options, but there is no single treatment suitable for everyone with PMOS.<\/p>\n
Paying Attention to Mental Health<\/strong><\/span><\/h3>\nAnxiety, depression, body image concerns, eating disorders, and psychological distress associated with infertility or excessive hair growth should not be dismissed as secondary issues. Mental health assessment and treatment should form part of comprehensive PMOS care. (ASRM)<\/p>\n
What Long-Term Complications Can PMOS Cause?<\/strong><\/span><\/h2>\nHaving PMOS does not mean that a person will necessarily experience all of the following complications. However, regular evaluation can help identify and manage risk factors at an early stage.<\/p>\n
Possible complications include:<\/p>\n
\n- Insulin resistance<\/li>\n
- Impaired glucose tolerance and type 2 diabetes<\/li>\n
- High blood pressure<\/li>\n
- Abnormal blood lipid levels<\/li>\n
- Sleep apnea<\/li>\n
- Psychological problems<\/li>\n
- An increased risk of certain pregnancy complications<\/li>\n
- Excessive thickening of the uterine lining when there are long intervals between menstrual periods<\/li>\n<\/ul>\n
The World Health Organization considers PMOS a chronic metabolic condition that may increase the long-term risk of certain health problems. (World Health Organization)<\/p>\n
Why Does the Change From PCOS to PMOS Matter?<\/strong><\/span><\/p>\n![\"\u0622\u06cc\u0627](\"https:\/\/drshojaeiazar.com\/wp-content\/uploads\/2026\/07\/pmos-2-1024x768.png\")
<\/p>\n
In medicine, the name of a condition can influence how it is understood, diagnosed, and treated.<\/p>\n
The name PMOS communicates several important messages.<\/p>\n
A Patient Does Not Need to Have Cysts to Be Diagnosed<\/strong><\/span><\/h3>\nPeople with hormonal symptoms or ovulatory dysfunction should not be denied a complete assessment simply because their ovaries appear normal on ultrasound.<\/p>\n
The Condition Is Not Only About Fertility<\/strong><\/span><\/h3>\nEven individuals who are not planning a pregnancy may require assessment of their blood glucose, blood lipid levels, blood pressure, sleep, and mental health.<\/p>\n
Visible Symptoms Are Also Part of the Condition<\/strong><\/span><\/h3>\nAcne, excessive hair growth, and thinning hair are not merely cosmetic concerns. They may be signs of hormonal changes.<\/p>\n
Care Should Be Patient-Centered<\/strong><\/span><\/h3>\nNot all affected individuals have the same symptoms, priorities, or risks. Treatment should be designed according to each person\u2019s goals, whether those goals involve regulating menstruation, controlling skin-related symptoms, improving metabolic health, or becoming pregnant.<\/p>\n
Do All Physicians Use the Name PMOS?<\/strong><\/span><\/h2>\nNo. The name change was announced in May 2026, and full implementation will take time. Both PCOS and PMOS will likely continue to appear for some time in scientific articles, medical records, prescriptions, and clinical discussions.<\/p>\n
The phrase \u201cPMOS, formerly known as PCOS\u201d may help maintain continuity in medical records and prevent patient confusion during the transition period.<\/p>\n
When Should You See a Doctor?<\/strong><\/span><\/h2>\nA medical evaluation is recommended if you experience any of the following signs:<\/p>\n
PMOS is the same condition that was previously known as PCOS, or polycystic ovary syndrome. This change does not mean that a new disease has been discovered. Instead, the new name is intended to better represent the true and complex nature of the condition.<\/p>\n
This syndrome may simultaneously affect several areas, including:<\/strong><\/p>\n International guidelines describe PMOS as the most common endocrine disorder during the reproductive years, with effects that may continue from adolescence through the years following menopause. (Monash University)<\/p>\n For several decades, the name PCOS was associated with scientific and communication-related problems. The term \u201cpolycystic\u201d led patients and even some healthcare providers to believe that the presence of multiple ovarian cysts was the main or essential feature of the condition.<\/p>\n The renaming process took approximately 14 years and involved specialists, researchers, people with lived experience of the condition, and 56 professional and patient advocacy organizations. More than 22,000 survey responses were collected. Criteria such as scientific accuracy, reduction of social stigma, suitability for use across different cultures, and improvement of medical care contributed to the selection of the new name. (Monash University)<\/p>\n One of the most important reasons for the name change is that affected individuals do not necessarily have ovarian cysts. What is observed in some ultrasound examinations is a collection of small follicles whose development or maturation has been interrupted.<\/p>\n On the other hand, a person may have polycystic ovarian morphology on ultrasound without meeting the other criteria required for the diagnosis of the syndrome. Therefore:<\/p>\n The World Health Organization also emphasizes that some affected individuals do not have polycystic ovarian morphology and that the presence of cysts is not necessary for diagnosis. (World Health Organization)<\/p>\n The name PCOS primarily directed attention toward the ovaries and fertility. However, the condition may also be associated with insulin resistance, impaired glucose tolerance, type 2 diabetes, abnormal blood lipid levels, sleep apnea, psychological problems, and an increased risk of certain pregnancy complications. (World Health Organization)<\/p>\n The name PMOS reminds both physicians and patients that evaluation of the condition should not be limited to an ovarian ultrasound or the treatment of menstrual irregularities.<\/p>\n Each component of the name PMOS represents one of the main dimensions of the condition.<\/p>\n Polyendocrine refers to the involvement of several hormonal pathways or systems. In PMOS, there is a complex interaction between ovarian hormones, androgens, insulin, and neuroendocrine signals.<\/p>\n Elevated androgen levels or increased sensitivity of the body to androgens may be associated with symptoms such as excessive hair growth, acne, and thinning of scalp hair.<\/p>\n The term \u201cmetabolic\u201d emphasizes the role of metabolism, particularly abnormalities in blood glucose regulation. Regardless of age or body mass index, affected individuals may have a greater risk of impaired glucose tolerance and type 2 diabetes.<\/p>\n International guidelines recommend assessing blood glucose status at the time of diagnosis and continuing subsequent evaluations based on individual risk factors. A 75-gram oral glucose tolerance test is the most accurate recommended method for assessing glucose status in PMOS, although a physician may also use fasting blood glucose or HbA1c in different circumstances. (ASRM)<\/p>\n Although PMOS extends beyond an ovarian disorder, ovarian function remains one of its central components. Abnormal follicular development, irregular or absent ovulation, and changes in menstrual cycles may affect fertility.<\/p>\n Therefore, the term \u201covarian\u201d has been retained in the new name, but the presence of \u201ccysts\u201d is no longer presented as the central feature of the condition.<\/p>\n No. PMOS is the same condition as PCOS, but with a more accurate name.<\/p>\n As a result of the name change:<\/p>\n During the transition period, physicians and healthcare centers may use terms such as \u201cPCOS\/PMOS\u201d or \u201cPMOS, formerly known as PCOS.\u201d The international transition plan is expected to take three years, with broader implementation of the new name continuing alongside the update of the international guidelines in 2028. (Monash University)<\/p>\n The symptoms of PMOS are not the same in every individual, and their severity may also change throughout life. Some people primarily experience menstrual problems, while others seek medical attention because of acne, excessive hair growth, weight gain, or difficulty becoming pregnant.<\/p>\n Irregular periods, long intervals between periods, or the absence of menstruation may result from irregular ovulation. Some individuals may also experience prolonged, heavy, or painful periods.<\/p>\n The growth of thick, dark hair on the face, chin, neck, chest, abdomen, or other areas of the body may be associated with elevated androgen levels.<\/p>\n Recurrent or treatment-resistant acne, particularly around the jawline, chin, and lower face, may be a sign of increased androgen activity.<\/p>\n Some affected individuals may experience hair loss or thinning in a pattern similar to androgenetic alopecia.<\/p>\n PMOS may be associated with increased abdominal fat or difficulty managing body weight. However, the condition does not occur only in people who are overweight. Individuals with a normal body weight may also have PMOS.<\/p>\n Irregular or absent ovulation can make it difficult to determine the appropriate timing for conception. PMOS is one of the common causes of infertility associated with ovulatory dysfunction, but a diagnosis does not mean that pregnancy is impossible. (World Health Organization)<\/p>\n Sleep apnea, anxiety, depression, body image concerns, and reduced quality of life are more common among some affected individuals. International guidelines recommend considering depression screening in affected adults and adolescents and anxiety screening in adults. (ASRM)<\/p>\n One of the most important messages conveyed by the new name is the greater emphasis placed on metabolic health.<\/p>\n Insulin is a hormone that helps glucose move from the bloodstream into the body\u2019s cells. In insulin resistance, the cells do not respond properly to this hormone, so the body produces more insulin to compensate.<\/p>\n Elevated insulin levels can stimulate the ovaries to produce more androgens. This process may worsen ovulation problems, menstrual irregularities, acne, and excessive hair growth.<\/p>\n However, insulin resistance is not the only cause of PMOS, and not all patients have the same metabolic symptoms. PMOS is a heterogeneous syndrome, and genetic, environmental, hormonal, and metabolic factors may all contribute to its development.<\/p>\n The new name PMOS does not replace clinical evaluation. Diagnosis must be made by a physician after reviewing the symptoms, menstrual history, physical examination findings, laboratory tests, and excluding other conditions with similar symptoms.<\/p>\n In adults, diagnosis is generally based on the presence of at least two of the following three criteria:<\/p>\n The presence of the first two criteria may allow a diagnosis to be made without ultrasound or AMH testing. In addition, AMH should not be used on its own to diagnose PMOS and is not currently recommended for the diagnosis of adolescents. (ASRM)<\/p>\n Diagnosis in adolescents should be approached more cautiously because menstrual irregularities and acne may be part of the normal process of puberty during the first few years after menstruation begins.<\/p>\n The use of ultrasound or AMH as diagnostic criteria is not recommended in adolescents. In cases where the complete diagnostic criteria are not met, the individual may be considered \u201cat risk of PMOS\u201d and reassessed in later years. (ASRM)<\/p>\n PMOS can affect fertility, but having the condition does not mean that infertility is inevitable. Many affected individuals become pregnant naturally or with appropriate treatment.<\/p>\n The main ways in which PMOS may affect fertility include:<\/strong><\/p>\n Before beginning infertility treatment, the physician evaluates not only ovulation but also age, ovarian reserve, the condition of the fallopian tubes, the partner\u2019s semen analysis, and other possible fertility factors.<\/p>\n No. IVF is only one of the available infertility treatments, and not everyone with PMOS requires it.<\/p>\n For women with infertility caused by anovulation who have no other infertility factors, international guidelines identify letrozole as the first-line medication for ovulation induction. Depending on the individual\u2019s circumstances, other options such as clomiphene, metformin, gonadotropins, intrauterine insemination, or IVF may also be considered. The treatment method must be selected under the supervision of a specialist. (ASRM)<\/p>\n At present, the name change itself has not created a new treatment. The main message of PMOS is that treatment should address all relevant aspects of the condition rather than focusing only on the ovaries or fertility.<\/p>\n A balanced diet, physical activity, adequate sleep, reduced sedentary behavior, and stress management are among the foundations of PMOS care.<\/p>\n International guidelines recommend healthy behaviors for all affected individuals, even when these changes do not result in weight loss. The goal is not only to reduce the number on the scale. Improving metabolic health, quality of life, body composition, and preventing weight gain are also important. (ASRM)<\/p>\n Combined oral contraceptive pills may be prescribed for some individuals to regulate menstrual cycles, reduce excessive hair growth, or control acne. The type of medication should be selected according to cardiovascular status, blood clot risk factors, the patient\u2019s preferences, and possible contraindications. (ASRM)<\/p>\n Metformin may be considered for some adults, particularly those with greater metabolic risk, to improve glucose-related indicators, insulin resistance, or blood lipid levels. This medication is not necessary for every patient and should only be used when prescribed by a physician. (ASRM)<\/p>\n Fertility treatment is selected according to the cause of infertility, age, ovulation status, and the individual\u2019s reproductive goals. Ovulation induction, timed intercourse, IUI, and IVF are among the possible options, but there is no single treatment suitable for everyone with PMOS.<\/p>\n Anxiety, depression, body image concerns, eating disorders, and psychological distress associated with infertility or excessive hair growth should not be dismissed as secondary issues. Mental health assessment and treatment should form part of comprehensive PMOS care. (ASRM)<\/p>\n Having PMOS does not mean that a person will necessarily experience all of the following complications. However, regular evaluation can help identify and manage risk factors at an early stage.<\/p>\n Possible complications include:<\/p>\n The World Health Organization considers PMOS a chronic metabolic condition that may increase the long-term risk of certain health problems. (World Health Organization)<\/p>\n Why Does the Change From PCOS to PMOS Matter?<\/strong><\/span><\/p>\n In medicine, the name of a condition can influence how it is understood, diagnosed, and treated.<\/p>\n The name PMOS communicates several important messages.<\/p>\n People with hormonal symptoms or ovulatory dysfunction should not be denied a complete assessment simply because their ovaries appear normal on ultrasound.<\/p>\n Even individuals who are not planning a pregnancy may require assessment of their blood glucose, blood lipid levels, blood pressure, sleep, and mental health.<\/p>\n Acne, excessive hair growth, and thinning hair are not merely cosmetic concerns. They may be signs of hormonal changes.<\/p>\n Not all affected individuals have the same symptoms, priorities, or risks. Treatment should be designed according to each person\u2019s goals, whether those goals involve regulating menstruation, controlling skin-related symptoms, improving metabolic health, or becoming pregnant.<\/p>\n No. The name change was announced in May 2026, and full implementation will take time. Both PCOS and PMOS will likely continue to appear for some time in scientific articles, medical records, prescriptions, and clinical discussions.<\/p>\n The phrase \u201cPMOS, formerly known as PCOS\u201d may help maintain continuity in medical records and prevent patient confusion during the transition period.<\/p>\n A medical evaluation is recommended if you experience any of the following signs:<\/p>\n\n
Why Was PCOS Renamed PMOS?<\/strong><\/span><\/h2>\n
<\/p>\nThe Term \u201cPolycystic\u201d Was Misleading<\/strong><\/span><\/h3>\n
\n
The Condition Is Not Limited to the Ovaries<\/strong><\/span><\/h3>\n
What Exactly Does PMOS Mean?<\/strong><\/span><\/h2>\n
Polyendocrine: Involvement of Multiple Hormonal Pathways<\/strong><\/span><\/h3>\n
Metabolic: The Importance of Metabolic Health<\/strong><\/span><\/h3>\n
Ovarian: The Continuing Importance of Ovarian Function<\/strong><\/span><\/h3>\n
Is PMOS a New Disease?<\/strong><\/span><\/h2>\n
\n
What Are the Symptoms of PMOS?<\/strong><\/span><\/h2>\n
Irregular Menstrual Cycles<\/strong><\/span><\/h3>\n
Excessive Hair Growth<\/strong><\/span><\/h3>\n
Acne and Oily Skin<\/strong><\/span><\/h3>\n
Thinning of Scalp Hair<\/strong><\/span><\/h3>\n
Weight Gain or Difficulty Managing Weight<\/strong><\/span><\/h3>\n
Ovulation and Pregnancy Difficulties<\/strong><\/span><\/h3>\n
Sleep and Mental Health Problems<\/strong><\/span><\/h3>\n
How Is Insulin Resistance Related to PMOS?<\/strong><\/span><\/h2>\n
<\/p>\nHow Is PMOS Diagnosed?<\/strong><\/span><\/h2>\n
\n
Diagnosing PMOS in Adolescents<\/strong><\/span><\/h3>\n
Does PMOS Cause Infertility?<\/strong><\/span><\/h2>\n
\n
Does Everyone With PMOS Need IVF?<\/strong><\/span><\/h2>\n
Is the Treatment of PMOS Different From the Treatment of PCOS?<\/strong><\/span><\/h2>\n
Lifestyle Modification<\/strong><\/span><\/h3>\n
Regulating Menstruation and Controlling Androgen-Related Symptoms<\/strong><\/span><\/h3>\n
Managing Metabolic Problems<\/strong><\/span><\/h3>\n
Treating Fertility Problems<\/strong><\/span><\/h3>\n
Paying Attention to Mental Health<\/strong><\/span><\/h3>\n
What Long-Term Complications Can PMOS Cause?<\/strong><\/span><\/h2>\n
\n
<\/p>\nA Patient Does Not Need to Have Cysts to Be Diagnosed<\/strong><\/span><\/h3>\n
The Condition Is Not Only About Fertility<\/strong><\/span><\/h3>\n
Visible Symptoms Are Also Part of the Condition<\/strong><\/span><\/h3>\n
Care Should Be Patient-Centered<\/strong><\/span><\/h3>\n
Do All Physicians Use the Name PMOS?<\/strong><\/span><\/h2>\n
When Should You See a Doctor?<\/strong><\/span><\/h2>\n